VivoSim Labs (VIVS) Stock Analysis: AI Score & Alternative Data
VIVS alt-data: web traffic climbing, sentiment lagging
Is VivoSim Labs a buy right now? The alternative data says hold. This VIVS stock analysis is built on the 25+ alternative data signals AltIndex tracks on VivoSim Labs every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 48/100: a Hold. The stock trades at $0.20 with a $3M market cap.
The bullish side of the 90-day ledger: web traffic up 133.7% to 2K monthly visits, and headcount (according to LinkedIn) up 6.5% to 33 employees. The drag: sentiment down 43.0% to 57/100. That tension is what keeps the score mid-range.
Every signal links to its own page with full history, the VIVS technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on VIVS is just below.
VivoSim Labs AI Stock Analysis
VivoSim Labs is a biotechnology firm focusing on advanced simulation technologies to enhance medical research and drug development. The company is recognized for its innovative methods in replicating complex biological systems, aiming to streamline and improve the overall efficacy of biomedical research.
Analysis generated October 2, 2026.
Recent VivoSim Labs Stock Alerts
|
VivoSim Labs | October 5 Price is up by 6.9% in the last 24h. |
|
VivoSim Labs | October 2 Price is down by -7.7% in the last 24h. |
|
VivoSim Labs | September 30 Price is up by 6% in the last 24h. |
|
VivoSim Labs | September 29 Price is down by -7.4% in the last 24h. |
VivoSim Labs Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 2K | 133.7% | |
| Job Posts | 0 | 100.0% | |
| LinkedIn Employees | 33 | 6.5% | |
| Sentiment | 57 | 43.0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 19 | 1,800.0% | |
| Stocktwits Mentions | 12 | 1,100.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 12K | 6.6% |
About VivoSim Labs (VIVS)
VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. The company is headquartered in San Diego, California.
| Price | $0.20 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $3M |
| Year Range | $0 – $3 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest VivoSim Labs News
View more →
VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCsSeptember 16 - Financial Post |
|
VivoSim Labs to Add Rat Liver Model to NAMkind PlatformSeptember 1 - Financial Post |
|
VivoSim Reports First Commercial Sales in China for NAMkind Testing Services (NASDAQ:VIVS)July 21 - Advfn.com |
|
VivoSim Provides Financial and Listing Compliance UpdateAugust 6 - GlobeNewswire |
|
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing ServicesJuly 21 - Financial Post |
|
See VivoSim Labs’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for VIVS, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEVivoSim Labs Earnings & Financial Performance
View all earnings →VivoSim Labs Insider Trading Activity
View all →| Lialin Tony Serge filed to sell 10,000 shares at $0.0. Aug 31 '26 |
| Gobel David filed to sell 0 shares at $0.0. Nov 17 '25 |
VivoSim Labs Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to VivoSim Labs
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Cadrenal TherapeuticsCVKD |
$0.99 4.7% | $3M | 49 |
 |
Moolec ScienceMLEC |
$4.83 0.7% | $4M | 48 |
 |
Geovax LabsGOVX |
$0.29 9.8% | $3M | 46 |
 |
Jupiter NeurosciencesJUNS |
$2.86 18.2% | $3M | 48 |
 |
Aptevo TherapeuticsAPVO |
$1.80 0.3% | $3M | 57 |
Explore VivoSim Labs Data
Frequently Asked Questions: VivoSim Labs (VIVS)
VivoSim Labs has an AltIndex AI Score of 48/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
48/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of VivoSim Labs (VIVS) stock is $0.20 with a market cap of $3M.
As of today, VivoSim Labs’s PE (Price to Earnings) ratio is —.
View the latest VivoSim Labs insider transactions to see recent buying and selling activity by company executives and directors.
Check the VivoSim Labs congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The VIVS stock price chart above shows VivoSim Labs’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full VivoSim Labs technical analysis for RSI, moving averages, and more.
See the stocks similar to VivoSim Labs section on this page for companies in the same industry ranked by market cap and AI Score.
